Risavie 550

Risavie 550

rifaximin

Manufacturer:

American Taiwan Biopharm

Distributor:

American Taiwan Biopharm

Marketer:

American Taiwan Biopharm
Concise Prescribing Info
Contents
Rifaximin
Indications/Uses
Reduction in recurrence of overt hepatic encephalopathy episodes in patients ≥18 yr.
Dosage/Direction for Use
Administration
May be taken with or without food: Take w/ glass of water.
Contraindications
Hypersensitivity to rifaximin or rifamycin-derivatives. Cases of intestinal obstruction.
Special Precautions
Clostridium difficile associated diarrhoea; pseudomembranous colitis. May cause reddish urine discolouration. Monitor INR if coadministration w/ warfarin is necessary. Not recommended in concomitant use w/ other rifamycins. Concomitant use w/ P-gp eg, ciclosporin. Renal impairment. Severe (Child-Pugh C) hepatic impairment; model for end-stage liver disease score >25. Not recommended during pregnancy. Lactation. Ped patients <18 yr.
Adverse Reactions
Depression; dizziness, headache; dyspnoea; upper abdominal pain, abdominal distension, diarrhoea, nausea, vomiting, ascites; rashes, pruritus; muscle spasms, arthralgia; peripheral oedema.
Drug Interactions
May decrease exposure of CYP3A4 substrates eg, warfarin, antiepileptics, antiarrhythmics, OCs in hepatic impaired patients. Decreased/increased INR w/ warfarin.
MIMS Class
Other Antibiotics
ATC Classification
A07AA11 - rifaximin ; Belongs to the class of antibiotics. Used in the treatment of intestinal infections.
Presentation/Packing
Form
Risavie 550 FC tab 550 mg
Packing/Price
3 × 10's
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in